Status:
COMPLETED
Prevalence of Periodontal Diseases in IBD
Lead Sponsor:
CHU de Reims
Conditions:
Inflammatory Bowel Diseases
Periodontal Diseases
Eligibility:
All Genders
18-70 years
Brief Summary
Periodontal diseases are highly prevalent inflammatory diseases. It is now well known that they are correlated with numerous systemic diseases as : diabetes, chronic obstructive pulmonary disease, met...
Detailed Description
The present study explores the prevalence of periodontal diseases regarding to the activity status of IBD (active versus non-active). Diseases activity will be assessed by HBI (Crohn's disease) or pa...
Eligibility Criteria
Inclusion
- Patients
- consulting Gastroenterology departments in the university hospital of Reims or Amiens-Picardie for the management of Crohn's disease or Ulcerative colitis
- signed informed consent form
- affiliated to the French Social Security system
Exclusion
- Patients presenting:
- a medical history likely to compromise protocol (psychiatric disorders, other inflammatory diseases, antibiotics, NSAIDs within the last 3 months)
- Diabetes
- Inflammatory rheumatism
- Cancer or radiotherapy up to5 years before inclusion
- X-ray therapy in the area of interest
- Pregnancy or Breastfeeding
- Eating disorders
- Patients under legal protection, trusteeship or guardianship
Key Trial Info
Start Date :
June 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 10 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04380922
Start Date
June 19 2020
End Date
June 10 2022
Last Update
June 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092